WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing more benefits of these powerful medicines, it’s no wonder appetite ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

Patients with well-compensated NASH cirrhosis and three metabolic risk factors were selected for inclusion in the study.

Ultra-processed food consumption in obese adolescents is linked to insulin resistance and liver disease, stressing the need ...

Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...

KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwideNew Delhi: University of ...

Liver function discovery may pave the way for improved treatments of cardiovascular diseases, offering new insights into ...